Welcome to our dedicated page for Capital Bancorp SEC filings (Ticker: CBNK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Capital Bancorp, Inc. filings document the regulatory disclosures of a Maryland bank holding company for Capital Bank, N.A. Recent Form 8-K reports cover quarterly and annual financial results, investor presentations, cash dividends, stock repurchase authorization, subordinated note redemption, and other material corporate events.
The company’s proxy and governance filings describe board structure, director elections and appointments, committee assignments, executive compensation, equity awards, and shareholder voting matters. Officer employment agreements and related compensatory arrangements appear in current reports, while capital-structure disclosures address common stock activity and bank holding company financing instruments.
Capital Bancorp (CBNK) reported an insider transaction by a director and officer (Pres, Specialty & CRE Lending). On 11/07/2025, the insider exercised stock options for 8,500 shares of common stock at $13.89 per share (code M) and disposed of 4,669 shares at $27.94 (code F).
Following these transactions, the insider directly beneficially owned 517,418 shares. The filing also lists remaining derivative holdings, including multiple stock option grants with stated exercise prices and vesting schedules, and 825 RSUs scheduled to vest in installments beginning 3/3/2026.
Capital Bancorp (CBNK) reported stronger Q3 2025 results. Net income was $15.1 million with diluted EPS of $0.89, up from $0.62 a year ago. Net interest income rose to $52.0 million from $38.4 million as higher loan yields drove revenue, while total noninterest income increased to $11.1 million from $6.6 million.
Total assets reached $3.39 billion. Portfolio loans were $2.83 billion versus $2.64 billion at year-end 2024, and deposits were $2.91 billion versus $2.76 billion. The allowance for credit losses was $53.0 million. Stockholders’ equity rose to $394.8 million, aided by improved accumulated other comprehensive loss of $(6.8) million.
The IFH acquisition accounting was finalized, increasing goodwill by $4.8 million to $26.0 million, with $0.7 million of merger-related expenses in Q3. Credit metrics were mixed: nonaccrual loans were $52.2 million at September 30, 2025 compared with $30.2 million at December 31, 2024. As of November 6, 2025, 16,520,863 common shares were outstanding.
Capital Bancorp Inc. (CBNK) reported an initial insider ownership statement for its SVP & CAO, signed by Connie Egan. The reporting person directly holds 3,884.7802 shares of common stock. Derivative holdings include stock options for 2,000 shares at $13.89 expiring 12/31/2025, 1,050 at $26.41 expiring 12/31/2026, 1,600 at $23.54 expiring 01/01/2028, 2,000 at $24.20 expiring 01/01/2029, and 1,339 at $30.51 expiring 03/03/2030. The filing also lists 361 restricted stock units that vest in four equal annual installments beginning on 3/3/26. The options vest in four equal annual installments beginning on the first anniversary of each grant.
Capital Bancorp, Inc. (CBNK) announced it will redeem all outstanding 5.00% Fixed-to-Floating Rate Subordinated Notes due 2030 on November 30, 2025. The outstanding balance is $10,000,000, and the redemption price will be 100% of principal plus accrued and unpaid interest to, but excluding, the redemption date.
This action retires debt five years ahead of the original maturity. The redemption removes interest obligations on these notes after November 30, 2025 and represents a cash outflow equal to principal plus accrued interest at settlement.
Capital Bancorp, Inc. (CBNK) furnished third‑quarter results via a press release and investor presentation covering the three and nine months ended September 30, 2025. These materials were provided under Item 2.02 and, along with the exhibits, are furnished—not deemed filed—under the Exchange Act.
The Board declared a cash dividend of $0.12 per share, payable on November 26, 2025 to stockholders of record on November 10, 2025. Related exhibits include the October 27, 2025 press release (Exhibit 99.1) and the September 2025 investor presentation (Exhibit 99.2).
Capital Bancorp (CBNK) executive Jacob Dalaya reported routine equity transactions. On 10/23/2025, 334 shares of common stock were acquired at $0 via the conversion of restricted stock units (code M). On the same day, 118 shares were withheld/disposed at $29.70 to cover taxes (code F). After these transactions, he directly owned 432 common shares.
Derivative holdings include stock options for 1,000 shares at $19.48 expiring 10/23/2028, 2,000 shares at $24.20 expiring 01/01/2029, and 3,445 shares at $30.51 expiring 03/03/2030, plus restricted stock units with vesting schedules beginning 10/23/2024 and 03/03/2026.
Capital Bancorp, Inc. announced a leadership transition in its finance function. On October 10, 2025, Executive Vice President and CFO Dominic C. Canuso informed the company of his resignation, effective October 27, 2025, to pursue another opportunity. The company stated his decision was not due to any disagreement regarding operations, policies, or practices.
Effective October 28, 2025, the Board appointed Connie Egan, age 64 and the Bank’s Chief Accounting Officer since September 2020, as the company’s Principal Financial and Accounting Officer while a nationwide search is conducted for a permanent CFO. Egan previously led Financial Planning and Analysis and served as CFO of Embassy National Bank for over seven years. The filing notes no family relationships, no related‑party transactions under Item 404(a), and no new or amended compensatory arrangements or additional grants associated with her appointment.
Capital Bancorp (CBNK) reported insider equity activity by President and COO Steven M. Poynot. On 10/11/2025, 666 common shares were acquired via the settlement of restricted stock units (transaction code M) at $0. The same day, 201 shares were disposed of (code F) at $28.76, typically for tax withholding.
Following these transactions, holdings were 1,397 shares direct and 5,253 shares indirect (by IRA). Derivative holdings include 1,131 RSUs and multiple option grants with scheduled vesting per the award terms.
Marc H. McConnell, a director of Capital Bancorp Inc (CBNK), reported multiple equity transactions dated 10/09/2025. He acquired 323 shares at $14.82 and 1,292 shares at $19.18, increasing his direct beneficial ownership to 13,434 shares. He also holds significant indirect positions: 156,926 shares via McConnell Legacy Investments, LLC, 3,345 via an IRA, 44,823 via a revocable trust, plus 557 shares each held indirectly for his son and daughter.
He received multiple stock options and 405 restricted stock units in a merger exchange; the options have various exercise prices and vesting schedules, with exercisability and expiration dates listed through 01/28/2031 and later. The RSU award vests on 03/03/2026. The form is signed by Mr. McConnell (by attorney-in-fact) on 10/10/2025.
Michael Breckheimer, SVP and Head of Windsor Advantage at Capital Bancorp Inc (CBNK), reported insider transactions dated 10/02/2025. He received 23,102 Restricted Stock Units (RSUs) (Code M) that vest on 10/02/2025, recorded at $0, which increased his direct beneficial ownership to 39,548 shares before a sale. On the same date he disposed of 7,127 shares (Code F) at a price of $31.04, leaving him with 32,421 shares beneficially owned. The filing also lists multiple stock option grants received in a merger with specified strike prices and vesting schedules and an additional 600 RSU grant vesting in four annual installments beginning 03/03/2026. The form is signed on 10/03/2025.